Johnson & Johnson
European approval for prostate cancer drug Zytiga
September 8, 2011Sales and Marketing Janssen, Jevtana, Johnson & Johnson, Zytiga, prostate cancer
Johnson & Johnson’s Zytiga has been approved in the EU for late-stage prostate cancer. Zytiga (abiraterone acetate) is now licenced …
Xarelto receives FDA approval
July 4, 2011Sales and Marketing Bayer, Eliquis, Johnson & Johnson, Pradaxa, Xarelto, anticoagulant
Bayer and Johnson & Johnson’s oral blood thinner Xarelto has been approved in the US for the prevention of deep …
J&J and Vertex’s hep C drug Incivek approved by FDA
May 24, 2011Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir
The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …
HIV drug Prezista recalled on TBA contamination
May 17, 2011Manufacturing and Production HIV, Johnson & Johnson, Prezista, manufacturing and production, recalls
Johnson & Johnson has recalled 11,700 bottles of its HIV treatment Prezista after consumer reports of a mouldy smell caused …
Prostate cancer drug Zytiga gains US approval
May 5, 2011Sales and Marketing Centocor Ortho Biotech, Johnson & Johnson, Zytiga, prostate cancer
Zytiga a new treatment for the most hard to treat cases of prostate cancer has been approved in the US. …
Top 5 reasons for a Class I product recall
April 21, 2011Manufacturing and Production Johnson & Johnson, product recalls
Having to recall a pharmaceutical product because of a major quality defect or safety issue is a heart sinking moment …
J&J and Merck reach compromise on arthritis drug rights
April 19, 2011Sales and Marketing Johnson & Johnson, Merck & Co, Remicade, Simponi
Johnson & Johnson and Merck & Co have agreed to split the regional rights to arthritis drugs Remicade and Simponi …
J&J reorganises McNeil as recalls keep coming
April 5, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, TBA, TCA, Tylenol, manufacturing compliance, pharma manufacturing, recalls, tribromoanisole, trichloroanisole
Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …
J&J hit by another string of product recalls
February 21, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls
There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …
Digital Pharma: Pfizer, J&J and Merck withdraw iPhone apps
January 7, 2011Medical Communications Android, Blackberry, Digital Pharma blog, Johnson & Johnson, Merck, Pfizer, apps, ipad, iphone
Big pharma companies have pulled a number of apps from the iTunes store, but it’s not a sign the industry …
Congressman says FDA should scrutinise J&J’s manufacturing partners
December 21, 2010Manufacturing and Production BestSweet, FDA, J&J, JJ, Johnson & Johnson, McNeil, Rolaids, manufacturing compliance, recalls
The latest flurry of recalls from Johnson & Johnson has prompted additional calls for a wide-ranging investigation of the company’s …
Race on to find new Johnson & Johnson leader
December 16, 2010Sales and Marketing Johnson & Johnson, recruitment
Johnson & Johnson is promoting two of its most senior executives as it prepares to replace William Weldon, its current …
Millions more OTC products recalled by J&J
November 29, 2010Manufacturing and Production Benadryl Allergy Fastmelt, J&J, JJ, Johnson & Johnson, Motrin, Rolaids, Tylenol, manufacturing compliance, recalls
Johnson & Johnson has been forced to announce yet another recall of over-the-counter medicines manufactured at its Fort Washington facility …
J&J and Takeda issue recall for cancer drug Velcade
November 22, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls
Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …
Pharma engages HTA bodies in early-stage drug discussions
October 27, 2010Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, EMA, European Medicines Agency, GlaxoSmithKline, Johnson & Johnson, health technology assessment, hta
Three pharma companies are taking part in a new pilot to harmonise European standards in health technology assessment (HTA). AstraZeneca, …
Latest content
Five Facts about cardiovascular disease
